X-twitter Facebook-square Youtube Instagram Rss

Andy Gray

Dr

Andy Gray

Senior Lecturer

TELEPHONE
031 260 4298

EMAIL
graya1@ukzn.ac.za

CAMPUS
Medical School

BIOSKETCH
Andy Gray BPharm, MSc (Pharm), PhD, FPS, FFIP is a pharmacist whose research interests include policy analysis (in particular, the development and implementation of National Medicines Policies), rational medicines use and the application of antiretroviral therapy in resource-constrained settings. He is a Senior Lecturer in the Division of Pharmacology, Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. He is co-director of the WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice. He is also Honorary Senior Scientist: Consultant Pharmacist for the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and non-executive Director of JEMBI Health Systems (NPC). Dr Gray is a Visiting Fellow in the Faculty of Pharmacy, Rhodes University, Makhanda. Dr Gray is a Fellow and Honorary Life Member of the Pharmaceutical Society of South Africa (PSSA) and a Fellow of the International Pharmaceutical Federation (FIP). He is a past President of the South African Association of Hospital and Institutional Pharmacists (SAAHIP) At the FIP, he served as President of the Hospital Pharmacy Section, Chairman of the Board of Pharmaceutical Practice and as a Vice-President. He is currently a Director of the FIP Foundation for Education and Research. He was appointed to the South African National Essential Medicines List Committee in 2013. He is currently chair of the Names and Scheduling Committee of the South African Health Products Regulatory Authority (SAHPRA) and serves on its Legal Committee and Pharmacovigilance Committee. He is a Member of the World Health Organization’s Expert Panel on Drug Policies and Management and has served as a member, rapporteur and co-chairperson of the Expert Committee on the Selection and Use of Essential Medicines, as chairperson of the sub-committee on Essential Medicines for Children, and on the WHO Guidelines Review Committee. Widely published, he has served as a reviewer for a number of international and local journals, is associate editor of the South African Pharmaceutical Journal, section editor of the Journal of Pharmaceutical Policy and Practice, and serves on the editorial boards of the International Journal of Clinical Pharmacy, Health Systems and Reform, BMC Health Services Research and the Journal of Pharmaceutical Health Services Research. He has also been a member of the editorial committee of the South African Health Review. Dr Gray has reviewed funding applications for several agencies, including the Health Systems Trust, National Research Foundation, Medical Research Council and UNITAID.He has been actively involved in the development and assessment of medicines and other health-related law in South Africa. Dr Gray is a member of the Rotary Club of Westville, and chairs two related Trusts: the Don McKenzie TB Trust and the Mike Strong Educational Trust.
Orcid
Scopus
Researchgate Profile
Google Scholar
RESEARCH INTERESTS
  • Policy analysis (particularly the processes of development and implementation of Medicines Policies)
  • Rational medicines use (particularly in the elderly and in relation to antimicrobial use).
  • The application of combination antiretroviral therapy (cART) in resource-constrained settings.
LIST OF PUBLICATIONS
Peer-reviewed journals
  1. Gray AL, Suleman F. Monitoring essential medicines access – unfinished business. Lancet Global Health (in press).
  2. Ndlovu N, Gray A, Blose N, Mokganya M. Health and Related Indicators 2023. In Moeti, T, Padarath A, Parkes J, Singh S, Ruff P (eds). South African Health Review 2023: strengthening cancer services. Health Systems Trust, Durban; 2024 (pp 172-240) (ISSN 1025-1715).
  3. Suleman F, Jama N, Meyer S, Gray A. Stakeholder perceptions of issues and possible solutions to access to oncology medicines – a case study of multi-stakeholder engagement. In Moeti T, Padarath A, Parkes J, Singh S, Ruff P (eds). South African Health Review 2023: strengthening cancer services. Health Systems Trust, Durban; 2024 (pp 50-59) (ISSN 1025-1715).
  4. Tlhaku K, Msimango L, Sookrajh Y, Milford C, Munatsi P, Gray A, Maraj M, Garrett N, Dorward J. Healthcare worker perspectives on adaptations to differentiated antiretroviral therapy delivery for people living with HIV during COVID-19 in South Africa. PLOS Global Public Health 2024; 4(8): e0003517.
  5. Gray AL, Suleman F. Unpacking the process of developing South Africa’s National Drug Policy – lessons for universal health coverage. Journal of Pharmaceutical Policy and Practice 2024;17(1): 2376349.
  6. Crowley T, Gray AL, Geyer N. Nurse prescribing and dispensing in South Africa: gaps in the current legislative framework. Health SA Gesondheid 2024; 29: a2582.
  7. Wirtz VJ, Gray AL, Sharma S, Sun J, Hogerzeil HV. Refocusing the World Health Organization’s Model List of Essential Medicines on the needs of low and middle income countries. BMJ 2024; 85: e077776.
  8. Ebrahim S, Blose N, Gloeck N, Hohlfeld A, Balakrishna Y, Muloiwa R, Gray A, Parrish A, Cohen K, Lancaster R, Kredo T. Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years: a systematic review and meta-analysis. PLOS Global Public Health 2023; 3(12): e0002676.
  9. Ndlovu N, Gray A, Mkhabela B, Myende N, Day C. Health and Related Indicators 2022. In Padarath A, Moeti T (eds). South African Health Review 2022 (pp 108-218). Health Systems Trust, Durban (ISSN 1025-1715; ISBN 9/8-1-928479-11-6).
  10. Gray A, Miot J, Mokgatle M, Rees H, on behalf of the Ministerial Advisory Committee on COVID-19. ‘Following the science’: the role of an independent advisory structure in the COVID-19 pandemic response and beyond. In Padarath A, Moeti T (eds). South African Health Review 2022 (pp 14-23). Health Systems Trust, Durban (ISSN 1025-1715; ISBN 9/8-1-928479-11-6).
  11. Joseph Davey DL, Wilkinson L, Grimsrud A, Nelson A, Gray A, Raphael Y, Wattrus C, Pillay Y, Bekker L-G. Urgent appeal to allow all professional nurses and midwives to prescribe pre-exposure prophylaxis (PrEP) in South Africa [editorial]. South African Medical Journal 2023; 113(8): e1191.
  12. Semete-Makoketlela B, Parrish A, Gray A, Blockman M, Rees H. Practising in a post-truth world – truth revision [letter]. South African Medical Journal 2023; 113(4): e809.
  13. Hlongwana SI, Gray AL. Barriers and facilitators to medicine collection through the CCMDD programme at a Durban Hospital. Health South Africa Gesondheid 2022; 27(0): a1906.
  14. Nelson A, Gray A, Bekker L-G, Grimsrud A, Wilkinson LS, Joseph Davey DL. Non-ART trained health-care workers needed to prescribe PrEP in South Africa [letter]. Lancet HIV 2022; 9(7): e458.
  15. Wilkinson M, Gray AL, Wiseman R, Kredo T, Cohen K, Miot J, Blecher M, Ruff P, Johnson Y, Poluta M, McGee S, Leong TD, Brand M, Suleman F, Maramba E, Jugathpal J, Cleary S, Nematswerani N, Moodliar S, Parrish A, Jamaloodien K, Stander T, McQuilkan K, Crisp N, Wilkinson T. Health technology assessment in support of National Health Insurance in South Africa. International Journal of Technology Assessment in Health Care 2022; 38(1): e44, 1–8.
 Book chapters and monographs 1.       Gray A, Suleman F. Pharmaceutical pricing in South Africa. In Babar Z (ed). Pharmaceutical Prices in the 21st Century. Springer International Publishing, Cham, 2015 (ISBN 978-3-319-12168-0)2.       Gray AL, Vawda YA. TRIPS, Access to Medicines and Local Production in South Africa. In Lofgren H, Williams O (eds). The New Political Economy of Pharmaceuticals. Production, Innovation and TRIPS in the Global South. Palgrave Macmillan, Basingstoke, 2013 (ISBN: 978-0-230-28463-0, ISBN10: 0-230-28463-9).3.       Day C, Gray A. Health and related indicators. In Padarath A, English R (eds). South African Health Review 2012/2013. Health Systems Trust, Durban, 2013 (ISBN 978-1-919839-73-8).4.       Gray A, Vawda Y, Jack C. Health policy and legislation. In Padarath A, English R (eds). South African Health Review 2012/2013. Health Systems Trust, Durban, 2013 (ISBN 978-1-919839-73-8).5.       Gray AL, Vitoria A (2012). Technical update on treatment optimization: pharmacological equivalence and clinical interchangeability of lamivudine and emtricitabine: a review of current literature. World Health Organization, Geneva, 2012 (ISBN 978-924-150381-5).6.       Gray A, Vawda Y, Jack C. Health policy and legislation. In Padarath A, English R (eds). South African Health Review 2011. Health Systems Trust, Durban, 2012 (ISBN: 978-1-919839-71-4).7.       Day C, Gray A, Budgell E. Health and related indicators. In Padarath A, English R (eds). South African Health Review 2011. Health Systems Trust, Durban, 2012 (ISBN: 978-1-919839-71-4).8.       Gray A, Suleman F. Medicines for chronic non-communicable diseases. In Phaswana-Mafuya N, Tassiopoulos D (eds). Non-communicable diseases in developing countries. Nova Science Publishers, Hauppauge NY, 2011 (ISBN: 978-1-61209-996-5).9.       Day C, Gray A. Health and related indicators. In Fonn S, Padarath A (eds). South African Health Review 2010. Health Systems Trust, Durban, 2010 (ISBN: 978-1-919839-69-1).10.    Gray A, Hoffman J, Mansfield PR. Pharmaceutical sales representatives. In Mintzes B, Mangin D, Hayes L (eds). Understanding and responding to pharmaceutical promotion: a practical guide. World Health Organization/Health Action International, Amsterdam, 2010. (also available in French, Spanish and Russian editions)11.   Gray A, Goodman B, Terán Puente JM, Mintzes B. Using unbiased prescribing information. In Mintzes B, Mangin D, Hayes L (eds). Understanding and responding to pharmaceutical promotion: a practical guide. World Health Organization/Health Action International, Amsterdam, 2010. (also available in French, Spanish and Russian editions)12.   Gray A. The challenges of implementing antiretroviral treatment in South Africa. In Abdool Karim SS and Abdool Karim Q (eds). HIV/AIDS in South Africa (2nd edition). Cambridge University Press, Cape Town, 2010 (ISBN: 978-0-521-14793-4). Unrefereed journals 1.       Gray A, Pharasi B. Taking stock – looking back over 20 years in order to look forward. South African Pharmaceutical Journal 2014; 81(5): 37-39.2.       Gray A. Biosimilars in rheumatology – has South Africa “jumped the gun”? South African Rheumatology Journal 2013; 5(2): 12-15.3.       Gray AL. Lessons from the FIP Centennial Congress and the Ministers’ Summit. South African Pharmaceutical Journal 2013; 80(3): 34-36.4.       Gray A, Suleman F. Training for clinical pharmacists – plat du jour or smörgåsbord? South African Pharmaceutical Journal 2012; 79(2): 38-40.5.       Gray A. Prescribing and dispensing by nurses – neglected steps in the legislative process. HIV Nursing 2010; 1(2): 28-31.6.        Gray A. Global standards, South African practice – report of a workshop. South African Pharmaceutical Journal 2010; 77(5): 45-48.7.       Gray A. Looking through the mirror … seeing the envisioned future? South African Pharmaceutical Journal 2010; 77(3): 50-51.8.       Gray A. Collaborative practice – more than just task shifting. South African Pharmaceutical Journal 2010; 77(1): 44-47.